Appoints Ron Borsheim as Chief Sales Officer - Aesthetics effective April 1, 2025

Zeo ScientifiX, Inc.

Base salary of $225,000 per year; option to purchase 40,000 shares at $2.50/share.
Option vests 50% on first anniversary, 50% on second anniversary; five-year term.
Borsheim has 30+ years experience in aesthetic and regenerative medicine sales, previously at Benev Company, Sofwave Medical, BTL Industries.
Severance: 1/4 month salary per 3 months completed after 90 days if terminated without cause or for good reason.
Position reports to CEO; remote work from Jacksonville Beach, FL with travel to headquarters.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ron Borsheim

Chief Sales Officer - Aesthetics

ZEOX · Zeo ScientifiX, Inc.

Effective: 2025-04-01
Filed: April 2, 2025, 7:59 PM ET

Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Ron Borsheim was appointed as Chief Sales Officer - Aesthetics at Zeo ScientifiX, Inc..

Action: appointed
Role: Chief Sales Officer - Aesthetics

Exact text from the filing

Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.

View on SEC.gov

Zeo ScientifiX, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-25-002326

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.